|
Volumn 16, Issue 24, 2006, Pages 6342-6347
|
Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2′-hydroxy-3′-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxyla te
|
Author keywords
A549 cells; Growth inhibition; Pyrazole derivatives
|
Indexed keywords
ACETONITRILE;
ANTINEOPLASTIC AGENT;
CARBOXYLIC ACID DERIVATIVE;
ETHYL 1 (2' HYDROXY 3' PHENOXYPROPYL) 3 (4' METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 (2' HYDROXY 3' PHENOXYPROPYL) 3 PHENYL 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [2' HYDROXY 3' (2' METHOXYPHENOXY)PROPYL] 3 (4' METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE.;
ETHYL 1 [2' HYDROXY 3' (2' METHOXYPHENOXY)PROPYL] 3 PHENYL 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [2' HYDROXY 3' (2' NITROPHENOXY)PROPYL] 3 (4' METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE.;
ETHYL 1 [2' HYDROXY 3' (2' NITROPHENOXY)PROPYL] 3 PHENYL 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [2' HYDROXY 3' (4' NITROPHENOXY)PROPYL] 3 (4' METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [2' HYDROXY 3' (4' NITROPHENOXY)PROPYL] 3 PHENYL 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [3' (4' CHLOROPHENOXY) 2' HYDROXYPROPYL] 3 (4' CHLOROPHENYL) 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 1 [3' (4' CHLOROPHENOXY) 2' HYDROXYPROPYL] 3 (4' METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE.;
ETHYL 1 [3' (4' CHLOROPHENOXY) 2' HYDROXYPROPYL] 3 PHENYL 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 3 (4' CHLOROPHENYL) 1 (2' HYDROXY 3' PHENOXYPROPYL) 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 3 (4' CHLOROPHENYL) 1 [2' HYDROXY 3' (2' METHOXYPHENOXY)PROPYL] 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 3 (4' CHLOROPHENYL) 1 [2' HYDROXY 3' (2' NITROPHENOXY)PROPYL] 1H PYRAZOLE 5 CARBOXYLATE;
ETHYL 3 (4' CHLOROPHENYL) 1 [2' HYDROXY 3' (4' NITROPHENOXY)PROPYL] 1H PYRAZOLE 5 CARBOXYLATE;
POTASSIUM CARBONATE;
PYRAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER INHIBITION;
CELL DIFFERENTIATION;
CELL GROWTH;
CELL VACUOLE;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
LUNG CANCER;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIVISION;
CELL LINE, TUMOR;
CELL SURVIVAL;
DRUG DESIGN;
ESTERS;
HUMANS;
LUNG NEOPLASMS;
MODELS, MOLECULAR;
PYRAZOLES;
|
EID: 33750806826
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2006.09.008 Document Type: Article |
Times cited : (125)
|
References (31)
|